These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7473536)

  • 1. Dexamethasone-suppressible hyperaldosteronism: clinical, biochemical and genetic relations.
    Connell JM; Inglis GC; Fraser R; Jamieson A
    J Hum Hypertens; 1995 Jun; 9(6):505-9. PubMed ID: 7473536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, biochemical and genetic features of five extended kindred's with glucocorticoid-suppressible hyperaldosteronism.
    Jamieson A; Slutsker L; Inglis G; Campbell M; Fraser R; White P; Connell J
    Endocr Res; 1995; 21(1-2):463-9. PubMed ID: 7588411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
    Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
    O'Mahony S; Burns A; Murnaghan DJ
    J Hum Hypertens; 1989 Aug; 3(4):255-8. PubMed ID: 2552113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial hyperaldosteronism].
    Spoto B; Furlò G; Gervasi A; Bresolin G; Zoccali C
    G Ital Nefrol; 2004; 21(2):139-43. PubMed ID: 15351948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-remediable aldosteronism.
    Halperin F; Dluhy RG
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-remediable aldosteronism.
    McMahon GT; Dluhy RG
    Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
    Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
    J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
    Connell JM; Jardine A; Fraser R
    Adv Nephrol Necker Hosp; 1990; 19():69-77. PubMed ID: 2154082
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
    Grim CE; Weinberger MH
    Pediatrics; 1980 Mar; 65(3):597-604. PubMed ID: 6987607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
    Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
    J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression.
    Jamieson A; Slutsker L; Inglis GC; Fraser R; White PC; Connell JM
    Clin Sci (Lond); 1995 May; 88(5):563-70. PubMed ID: 7614815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
    Corvol P; Soubrier F; Jeunemaitre X
    Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
    Nicod J; Dick B; Frey FJ; Ferrari P
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
    Ding W; Liu L; Hu R; Xu M; Chen J
    Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
    New MI; Peterson RE; Saenger P; Levine LS
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
    Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone].
    Jakob F; Seufert J; Haack D; Schröder K; Ludwig J; Rendl J; Vecsei P
    Dtsch Med Wochenschr; 1993 Dec; 118(50):1837-43. PubMed ID: 8269828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting hypertension: the role of the 'new genetics'.
    Jamieson A
    J R Coll Physicians Lond; 1994; 28(6):512-8. PubMed ID: 7884706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.